Literature DB >> 22303896

HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.

Iordanis E Evangelou1, Raya Massoud, Steven Jacobson.   

Abstract

BACKGROUND: Human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a disabling neurological disorder characterized by inflammatory changes in the spinal cord. We used a semiautomatic technique to quantify spinal cord volume from 3-dimensional MR images of patients with HAM/TSP.
METHODS: Five patients and 5 matched healthy volunteers (HVs) underwent MRI of the cervical and thoracic spinal cord at 1.5 T. Quantification of the spinal cord volume was obtained from 3-dimensional MR images using a semiautomatic technique based on level sets. An unpaired t-test was used to assess statistical significance.
RESULTS: Significant differences were found between mean spinal cord volume of HVs and HAM/TSP patients. The thoracic spinal cord volume was 14,050 ± 981 mm(3) for HVs and 8,774 ± 2,218 mm(3) for HAM/TSP patients (P = .0079), a reduction of 38%. The cervical spinal cord volume was 9,721 ± 797 mm(3) for HVs and 6,589 ± 897 mm(3) for HAM/TSP patients (P = .0079), a reduction of 32%. These results suggest that atrophy is evident throughout the spinal cord not routinely quantified.
CONCLUSIONS: Semiautomatic spinal cord volume quantification is a sensitive technique for quantifying the extent of spinal cord involvement in HAM/TSP.
Copyright © 2012 by the American Society of Neuroimaging.

Entities:  

Keywords:  HAM/TSP; HTLV-I; MRI; Spinal cord; atrophy

Mesh:

Year:  2012        PMID: 22303896      PMCID: PMC4687900          DOI: 10.1111/j.1552-6569.2011.00648.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  11 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

3.  Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.

Authors:  C Griffith; F Bagnato; S Gupta; A Calabrese; U Oh; A Chiu; J M Ohayon; M J McAuliffe; T A Tasciyan; S Jacobson
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

4.  Human T cell lymphotropic virus type 1-associated myelopathy in São Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort.

Authors:  Antonio C P Milagres; Maria Lúcia S G Jorge; Paulo E Marchiori; Alusio A C Segurado
Journal:  Neuroepidemiology       Date:  2002 May-Jun       Impact factor: 3.282

5.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

Authors:  Y Iwasaki
Journal:  J Neurol Sci       Date:  1990-04       Impact factor: 3.181

6.  Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images.

Authors:  Motohiro Yukitake; Yukinori Takase; Yusuke Nanri; Masafumi Kosugi; Makoto Eriguchi; Yusuke Yakushiji; Ryuichiro Okada; Haruo Mizuta; Yasuo Kuroda
Journal:  Intern Med       Date:  2008-11-04       Impact factor: 1.271

7.  Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study.

Authors:  J R Orland; J Engstrom; J Fridey; R A Sacher; J W Smith; C Nass; G Garratty; B Newman; D Smith; B Wang; K Loughlin; E L Murphy
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

8.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

9.  Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?

Authors:  F Umehara; S Nagatomo; K Yoshishige; M Saito; Y Furukawa; K Usuku; M Osame
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

10.  Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy.

Authors:  Fujio Umehara; Hirohisa Nose; Mineki Saito; Michinari Fukuda; Mieko Ogino; Tomoko Toyota; Tomoaki Yuhi; Kimiyoshi Arimura; Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

View more
  7 in total

1.  Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.

Authors:  Monique R Anderson; Yoshimi Enose-Akahata; Raya Massoud; Nyater Ngouth; Yuetsu Tanaka; Unsong Oh; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-21       Impact factor: 4.147

2.  In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.

Authors:  Winston Liu; Govind Nair; Luisa Vuolo; Anshika Bakshi; Raya Massoud; Daniel S Reich; Steven Jacobson
Journal:  Ann Neurol       Date:  2014-07-22       Impact factor: 10.422

Review 3.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

4.  Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Carlos Vilchez; Massiel Gonzalez-Reinoso; Caroline Cubbison; Eddy Perez-Then; Pedro Roa; Adriano Martínez; Bernd Foerster; Jairo Oviedo; Peter Stoeter
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643

5.  Comprehensive Analysis of TCR-β Repertoire in Patients with Neurological Immune-mediated Disorders.

Authors:  Alessandra de Paula Alves Sousa; Kory R Johnson; Joan Ohayon; Jun Zhu; Paolo A Muraro; Steven Jacobson
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

6. 

Authors:  Sheila N F Liberato de Matos; Giovanna Ladeia-Rocha; José Abraão Carneiro Neto; Cassius J V de Oliveira; César Araújo Neto; Lúcia Passos; Jamary Oliveira-Filho; Edgar M Carvalho
Journal:  Ann Clin Transl Neurol       Date:  2022-03-09       Impact factor: 4.511

7.  Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes.

Authors:  Monique R Anderson; Michelle L Pleet; Yoshimi Enose-Akahata; James Erickson; Maria Chiara Monaco; Yao Akpamagbo; Ashley Velluci; Yuetsu Tanaka; Shila Azodi; Ben Lepene; Jennifer Jones; Fatah Kashanchi; Steven Jacobson
Journal:  Clin Transl Med       Date:  2018-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.